Growth Metrics

Pacific Biosciences Of California (PACB) Revenue Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 7.78%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 2.63%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 8.74%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 11.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 16.70%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 6.08%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 15.05%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 7.41%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 7.29%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 0.07%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 0.07%
Dec 31, 2025 13.82%
Sep 30, 2025 -3.82%
Jun 30, 2025 10.42%
Mar 31, 2025 -4.27%
Dec 31, 2024 -32.79%
Sep 30, 2024 -28.23%
Jun 30, 2024 -24.30%
Mar 31, 2024 -0.23%
Dec 31, 2023 113.35%
Sep 30, 2023 72.36%
Jun 30, 2023 34.13%
Mar 31, 2023 17.26%
Dec 31, 2022 -24.06%
Jun 30, 2022 15.87%
Mar 31, 2022 14.40%
Dec 31, 2021 32.74%
Jun 30, 2021 79.25%
Mar 31, 2021 85.90%
Dec 31, 2020 -2.84%
Sep 30, 2020 -12.93%
Jun 30, 2020 -30.64%
Mar 31, 2020 -5.04%
Dec 31, 2019 43.04%
Sep 30, 2019 20.68%
Jun 30, 2019 14.10%
Mar 31, 2019 -15.17%
Dec 31, 2018 -21.69%
Sep 30, 2018 -22.87%
Jun 30, 2018 7.50%
Mar 31, 2018 -22.29%
Dec 31, 2017 -3.06%
Sep 30, 2017 -6.26%
Jun 30, 2017 -3.25%
Mar 31, 2017 30.26%
Dec 31, 2016 -29.10%
Sep 30, 2016 80.48%
Jun 30, 2016 -16.81%
Mar 31, 2016 8.40%
Dec 31, 2015 114.63%
Sep 30, 2015 -32.52%
Jun 30, 2015 118.28%
Mar 31, 2015 51.56%
Dec 31, 2014 85.07%
Sep 30, 2014 177.90%
Jun 30, 2014 88.91%
Mar 31, 2014 108.71%
Dec 31, 2013 55.39%
Sep 30, 2013 167.33%
Jun 30, 2013 -17.05%
Mar 31, 2013 -44.43%
Dec 31, 2012 -82.26%
Sep 30, 2012 -71.73%
Jun 30, 2012 3,697.40%
Mar 31, 2012 3,617.78%
Dec 31, 2011 11,733.93%
Sep 30, 2011 4,363.18%
Jun 30, 2011 -69.48%